Wuhu decoction combined with azithromycin for treatment of Mycoplasma pneumoniae pneumonia in Asian children: a systematic review and meta analysis of randomized controlled trials

Wuhu decoction combined with azithromycin for treatment of Mycoplasma pneumoniae pneumonia in Asian children: a systematic review and meta analysis of randomized controlled trials

Objective: This study constitutes a pioneering systematic review and meta analysis delving into the clinical efficacy and safety of the combined therapy involving Wuhu Decoction and azithromycin for treating Mycoplasma pneumoniae pneumonia in pediatric patients.Methods: This study conducted a compre...

Full description

Bibliographic Details
Main Authors:	Shuo Yang, Xinying Liu, Huizhe Wang, Haokai Wang, Dan Sun, Yaowei Han, Huanmin Li, Xinmin Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Pharmacology
Subjects:	Wuhu decoction Mycoplasma pneumoniae pneumonia systematic review meta analysis clinical research
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1329516/full

Similar Items

Risk Factors for Severe Mycoplasma Pneumoniae Pneumonia in Children: a Meta-analysis
by: YANG Shuo, LIU Xinying, WANG Huizhe, LI Huanmin, LI Xinmin
Published: (2024-05-01)

Risk factors for complications of Mycoplasma pneumoniae pneumonia in hospitalized children in China: a systematic review and meta-analysis
by: Ziyu Wang, et al.
Published: (2024-12-01)

Clinical Effects of Traditional Chinese Medicine + Azithromycin in the Treatment of Mycoplasma Pneumonia
by: Zhang G, et al.
Published: (2025-02-01)

Shuanghuanglian oral preparations combined with azithromycin for treatment of Mycoplasma pneumoniae pneumonia in Asian children: A systematic review and meta-analysis of randomized controlled trials.
by: Yingying Peng, et al.
Published: (2021-01-01)

Azithromycin Effectiveness in Children with Mutated Mycoplasma Pneumoniae Pneumonia
by: Cheng J, et al.
Published: (2024-07-01)

The rational dose for MaXingShiGan decoction is crucial for its clinical effectiveness in treating bronchial pneumonia: three randomized, double-blind, dose-parallel controlled clinical studies
by: Xuedong An, et al.
Published: (2023-11-01)

Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial
by: Yujiao Zheng, et al.
Published: (2022-09-01)

Maxing Shigan Decoction Mitigates Mycoplasma pneumonia-Induced Pyroptosis in A549 Cells via the NLRP3 Inflammasome
by: Liu F, et al.
Published: (2021-03-01)

Clinical Characteristics of Lung Consolidation with Mycoplasma pneumoniae Pneumonia and Risk Factors for Mycoplasma pneumoniae Necrotizing Pneumonia in Children
by: Xue Zhang, et al.
Published: (2024-01-01)

A comparative study of general and severe mycoplasma pneumoniae pneumonia in children
by: Shuo Yang, et al.
Published: (2024-04-01)

Association of atopy with disease severity in children with Mycoplasma pneumoniae pneumonia
by: ChenRong Bian, et al.
Published: (2023-11-01)

Efficacy of azithromycin combined with intravenous immunoglobulin in the treatment of refractory mycoplasma pneumoniae pneumonia in children: a meta-analysis
by: Yuan-yuan Shen, et al.
Published: (2024-10-01)

Research on the metabolic regulation mechanism of Yangyin Qingfei decoction plus in severe pneumonia caused by Mycoplasma pneumoniae in mice
by: Tianyu Zhang, et al.
Published: (2024-04-01)

The value of CT radiomic in differentiating mycoplasma pneumoniae pneumonia from streptococcus pneumoniae pneumonia with similar consolidation in children under 5 years
by: Dongdong Wang, et al.
Published: (2022-09-01)

Chest CT characterization of children with necrotizing pneumonia due to Mycoplasma pneumoniae infection
by: Jiapu Hou, et al.
Published: (2025-02-01)

Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children
by: Beilei Yang, et al.
Published: (2021-08-01)

Clinical Efficacy and Safety of Shashen Maidong Decoction in the Treatment of Pediatric Mycoplasma Pneumonia: A Systematic Review and Meta-Analysis
by: Jiawei Wang, et al.
Published: (2021-10-01)

Clinical characteristics and predictive indictors of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective study
by: Yun Li, et al.
Published: (2024-12-01)

Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia
by: Xia Huang, et al.
Published: (2021-01-01)

Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity
by: Yong-tao Li, et al.
Published: (2023-10-01)

Immune response plays a role in Mycoplasma pneumoniae pneumonia
by: Yifan Zhu, et al.
Published: (2023-05-01)

Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children
by: Meijuan Wang, et al.
Published: (2014-12-01)

Risk Prediction Model for Necrotizing Pneumonia in Children with Mycoplasma pneumoniae Pneumonia
by: Luo Y, et al.
Published: (2023-05-01)

Neutrophil-to-lymphocyte ratio as a predictor of poor outcomes of Mycoplasma pneumoniae pneumonia
by: Dan Li, et al.
Published: (2023-12-01)

Characteristics and Outcomes of Mycoplasma Pneumoniae Pneumonia Associated with Pulmonary Embolism and Necrotizing Pneumonia in Children
by: Wang C, et al.
Published: (2024-05-01)

Effect of Yinlai Decoction on the metabolic pathways in the lung of high-calorie diet-induced pneumonia rats
by: Fuyang Xian, et al.
Published: (2021-01-01)

Comparison of efficacy and safety of doxycycline versus azithromycin for mycoplasma pneumonia in children over 8 years old
by: WANG Shengquan, HUA Ying, SUN Mingxia, MA Jiawei, ZHANG Weihon,g WU Guoqin, LIU Ji
Published: (2025-01-01)

Characterization of diffuse lung function in children with Mycoplasma pneumoniae pneumonia
by: Li Wang, et al.
Published: (2025-01-01)

A compendium for Mycoplasma pneumoniae
by: Gretchen Lynn Parrott, et al.
Published: (2016-04-01)

The impact of atopy on the clinical characteristics of mycoplasma pneumoniae pneumonia in pediatric patients
by: Yujie Qin, et al.
Published: (2025-01-01)

Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain
by: Ana Dacosta Urbieta, et al.
Published: (2024-12-01)

Style Transfer of Chinese Wuhu Iron Paintings Using Hierarchical Visual Transformer
by: Yuying Zhou, et al.
Published: (2024-12-01)

Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
by: Masato Tashiro, et al.
Published: (2017-12-01)

Construction and Validation of a Nomogram Model to Predict the Severity of Mycoplasma pneumoniae Pneumonia in Children
by: Li L, et al.
Published: (2024-02-01)

Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children
by: Lanqin Chen, et al.
Published: (2023-03-01)

Prediction of risk factors of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia
by: Jiahui Zhang, et al.
Published: (2021-01-01)

Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children: a review
by: Li Gao, et al.
Published: (2024-12-01)

Construction of a Nomogram for Identifying Refractory Mycoplasma pneumoniae Pneumonia Among Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
by: Xie Q, et al.
Published: (2022-11-01)

Clinical Role of Serum Interleukin-17A in the Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children
by: Zhao J, et al.
Published: (2020-03-01)

Clinical significance of Mycoplasma pneumoniae specific IgM titer in children hospitalized with Mycoplasma pneumoniae pneumonia
by: Soojeong Choo, et al.
Published: (2022-05-01)